Global Sustained Release Excipients Market Projected to Surpass $2.13 Billion by 2029 with 9% Annual Growth

Which drivers are expected to have the greatest impact on the over the sustained release excipients market's growth?
The surge in chronic and acute illnesses is forecasted to stimulate the sustained-release excipients market's expansion. Chronic and acute disorders are two separate classifications that categorize illnesses based on their duration and progression. By definition, chronic illnesses are long-term health conditions that persist for an extended period, generally three months or more, while acute illnesses are known for rapid symptom onset, usually severe but transient in nature. These diseases develop abruptly and typically last only briefly, from hours to days or weeks. Sustained-release excipients are extensively utilized in the pharmaceutical field for the formulation of products to treat both types of diseases. They elevate patient adherence, stabilize drug levels, mitigate side effects, and enhance disease management, thus promoting the sales of sustained-release excipients. For instance, according to the World Health Organization (WHO), a specialized health agency based in Switzerland, announced in September 2022 that cardiovascular diseases lead the causes of NCD deaths with 17.9 million people each year, followed by chronic respiratory illnesses (4.1 million), diabetes (2.0 million, including deaths from kidney disease triggered by diabetes), and cancer (9.3 million). Also, the American College of Cardiology, a non-profit medical association in the US, reported in August 2022 that it is predicted that all four key cardiovascular risk factors in the United States will experience an increase from 2025 to 2060. Diabetes is slated to witness the most substantial percentage growth with a 39.3% hike to 55 million people, followed by dyslipidemia (an increase of 27.6% to 126 million), hypertension (a rise of 25.1% to 162 million), and obesity (up by 18.3% to 126 million). Additionally, considerable increases in cardiovascular disease rates like stroke (up by 33.8% to 15 million) and heart failure (up by 33.4% to 13 million) are forecasted, with ischemic heart disease (up by 30.7% to 29 million) and heart attack (up by 16.9% to 16 million) following suit. Therefore, the escalating prevalence of chronic and acute diseases spurs the growth of the sustained-release excipients market.

Get Your Sustained Release Excipients Market Report Here:
https://www.thebusinessresearchcompany.com/report/sustained-release-excipients-global-market-report

What is the future CAGR of the sustained release excipients market, and how will it impact industry expansion?
The size of the market for sustained release excipients has seen considerable growth in the past few years. It is projected to increase from a value of $1.4 billion in 2024 to $1.53 billion in 2025, boasting a compound annual growth rate (CAGR) of 9.1%. Factors contributing to growth during the historical period include a rising demand for controlled drug release, the prevalence of chronic diseases, patient convenience and compliance, innovation in the pharmaceutical industry, and regulatory backing for extended-release formulations.

There is predicted to be a substantial increase in the size of the sustained release excipients market in the coming years, expected to achieve a value of "$2.13 billion by the year 2029, thanks to a compound annual growth rate (CAGR) of 8.8%. This expansion throughout the estimated period can be credited to factors such as a rising elderly population, an emphasis on tailor-made medicine, hurdles in patient adherence, an upsurge in intricate drug formulations, and progress in disease control, besides overall growth of global healthcare. Key trends for the prediction period encompass patient-focused drug administration, partnerships contributing to formulation development, adherence to regulation and safety, international proliferation of drug formulation technologies, and the impact of biopharmaceuticals.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp

What are the most significant trends transforming the sustained release excipients market today?
A key trend emerging in the sustained release excipients market is product innovation. This strategy is being employed by key market players aiming to consolidate their market positions through the creation of novel products. For instance, Nutriventia Limited, a pharmaceutical company based in India, launched Prolanza - a sustained-release ingredient derived from the ashwagandha plant (Withania somnifera), in September 2022. Prolanza is a sophisticated extract of the ashwagandha root, designed to provide consistent support in terms of stress reduction. Its unique release system enables it to display its therapeutic properties for an extended period, requiring just a single dose daily. In a comparison with a control component, Prolanza demonstrated superior relative absorption, improved bioavailability, and a longer elimination half-life, indicating its sustained-release profile. As ashwagandha is typically utilized for its ability to modulate and mitigate stress responses, Prolanza's therapeutic effects are expected to last longer and provide more significant overall health benefits. Prolanza is made from natural herbs and its effectiveness has been scientifically validated.

Which key market segments comprise the sustained release excipients market and drive its revenue growth?
The sustained release excipients market covered in this report is segmented -

1) By Product: Gelatin, Polymers, Minerals, Sugars, Alcohol, Chitosan
2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation

Subsegments:
1) By Gelatin: Type A Gelatin, Type B Gelatin
2) By Polymers: Natural Polymers, Synthetic Polymers
3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients
4) By Sugars: Sucrose, Lactose, Glucose, Other Sugars
5) By Alcohol: Ethanol, Isopropyl Alcohol, Other Alcohols
6) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10822

What regions are at the forefront of sustained release excipients market expansion?
North America was the largest region in the global sustained release excipients market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the leading players fueling growth in the sustained release excipients market?
Major companies operating in the sustained release excipients market include BASF SE, Ashland Global Holdings Inc., Colorcon Inc., Croda International Plc, Dow Chemical Company, DuPont de Nemours Inc., Roquette Frères, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, JRS Pharma GmbH & Co. KG, Shin-Etsu Chemical Co.Ltd., Gattefossé SAS, Eastman Chemical Company, Cellulose Solutions Private Limited, Avantor Inc., SPI Pharma Inc., Asahi Kasei Corporation, Chemische Fabrik Budenheim KG, Associated British Foods plc, Ransom Naturals Ltd, Balchem Corporation, IMCD Group, Lonza Group AG

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=10822&type=smp

What Is Covered In The Sustained Release Excipients Global Market Report?

• Market Size Forecast: Examine the sustained release excipients market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the sustained release excipients market for a structured understanding.
• Key Players Overview: Analyze major players in the sustained release excipients market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the sustained release excipients market.
• Segment Contributions: Evaluate how different segments drive overall growth in the sustained release excipients market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the sustained release excipients market.
• Industry Challenges: Identify potential risks and obstacles affecting the sustained release excipients market.
• Competitive Landscape: Review strategic developments in the sustained release excipients market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.